We are live on ! Find out more
Goldman Sachs

Goldman Sachs Portfolio holdings

AUM $871B
1-Year Est. Return 31.28%
 

Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.

This Fund
S&P 500
This Quarter Est. Return
+8.54%
1 Year Est. Return
+31.28%
3 Year Est. Return
+94.73%
5 Year Est. Return
+114.04%
10 Year Est. Return
+476.55%
AUM
$446B
AUM Growth
+$49.9B
Cap. Flow
+$20.1B
Cap. Flow %
4.51%
Top 10 Hldgs %
17.27%
Holding
6,869
New
821
Increased
2,556
Reduced
2,333
Closed
700

Sector Composition

Rank Sector Weight
1 Technology 14.59%
2 Consumer Discretionary 9.73%
3 Financials 8.55%
4 Healthcare 8.03%
5 Communication Services 6.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MACQW
5926
DELISTED
MCAP Acquisition Corporation Warrants
MACQW
$72K ﹤0.01%
+67,959
New +$59.9K
AYTU icon
5927
AYTU BioPharma
AYTU
$23.9M
$71K ﹤0.01%
706
-3,192
-82% -$374K
GNE icon
5928
Genie Energy
GNE
$367M
$71K ﹤0.01%
11,204
-60,605
-84% -$371K
MACAW
5929
DELISTED
Moringa Acquisition Corp Warrant
MACAW
$71K ﹤0.01%
+93,287
New +$59.2K
AENTW icon
5930
Alliance Entertainment Holding Corp Warrants
AENTW
$3.57M
$70K ﹤0.01%
104,273
+5,795
+6% +$3.13K
CMCM
5931
Cheetah Mobile
CMCM
$86.6M
$70K ﹤0.01%
5,871
-5,003
-46% -$56.2K
NVCN
5932
DELISTED
Neovasc Inc.
NVCN
$70K ﹤0.01%
+3,028
New +$69K
TANH icon
5933
Tantech Holdings
TANH
$6.07M
$69K ﹤0.01%
6
-7
-54% -$83K
SBII.WS
5934
DELISTED
Sandbridge X2 Corp. Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share
SBII.WS
$69K ﹤0.01%
+66,170
New +$57.1K
CRVS icon
5935
Corvus Pharmaceuticals
CRVS
$1.12B
$68K ﹤0.01%
25,583
-5,221
-17% -$14.4K
GRDX
5936
GridAI Technologies Corp
GRDX
$20.4M
$68K ﹤0.01%
+1
New +$108K
VATE icon
5937
INNOVATE Corp
VATE
$111M
$67K ﹤0.01%
1,686
+212
+14% +$8.57K
MIST icon
5938
Milestone Pharmaceuticals
MIST
$138M
$66K ﹤0.01%
12,004
DNZ.WS
5939
DELISTED
D and Z Media Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
DNZ.WS
$66K ﹤0.01%
+70,637
New +$56.8K
VANIW
5940
DELISTED
Vivani Medical, Inc. Warrants expiring 03/14/2024
VANIW
$65K ﹤0.01%
54,247
+8,217
+18% +$11.1K
EBON icon
5941
Ebang International Holdings
EBON
$12.3M
$62K ﹤0.01%
+669
New +$75.2K
SGLY icon
5942
Singularity Future Technology
SGLY
$4.69M
$62K ﹤0.01%
+138
New +$80.1K
FZT.WS
5943
DELISTED
FAST Acquisition Corp. II Redeemable warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share
FZT.WS
$62K ﹤0.01%
+50,000
New +$50.1K
NH
5944
DELISTED
NantHealth, Inc
NH
$61K ﹤0.01%
+1,768
New +$70.3K
RKTO
5945
Rocket One Inc
RKTO
$17.9M
$60K ﹤0.01%
+1,498
New +$58.6K
PULM icon
5946
Pulmatrix
PULM
$6.35M
$60K ﹤0.01%
2,904
-4,109
-59% -$83.2K
SNGX icon
5947
Soligenix
SNGX
$5.54M
$60K ﹤0.01%
+225
New +$65.9K
VCNX
5948
DELISTED
Vaccinex, Inc. Common Stock
VCNX
$60K ﹤0.01%
102
+5
+5% +$2.64K
HCIIW
5949
DELISTED
Hudson Executive Investment Corp. II Warrant
HCIIW
$60K ﹤0.01%
50,000
BCTX
5950
Briacell Therapeutics
BCTX
$29.9M
$59K ﹤0.01%
+74
New +$46.1K

Similar funds

Goldman Sachs's Q2 2021 Portfolio in Review

As of Q2 2021, Goldman Sachs held 6,869 positions worth $446B, up 13% from $396B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Goldman Sachs deployed $20.1B of net new capital in Q2 2021, opening 821 new positions and adding to 2,556 existing holdings. Its largest new stake was Privia Health: 30,513,629 shares worth $1.35B.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, an estimated $960M trimmed.

  • Goldman Sachs's largest Q2 2021 buy was Privia Health: 30,513,629 shares worth $1.35B.
  • Goldman Sachs added most to Alibaba in Q2 2021, an estimated $1.31B increase.
  • Goldman Sachs's biggest Q2 2021 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $960M.
  • Goldman Sachs fully exited Pluralsight, Inc. Class A Common Stock in Q2 2021, selling an estimated $128M.
  • Goldman Sachs's ten largest holdings make up 17% of its $446B portfolio in Q2 2021.
  • Goldman Sachs opened 821 new positions and closed 700 in Q2 2021.
  • Goldman Sachs's portfolio value rose 13% quarter-over-quarter to $446B.

Based on Goldman Sachs's 13F filing for Q2 2021, filed 13 Aug 2021.